All In Biotech

Drug Trial Radar · NCT05928780

An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2)

A Molecular Pathway-based Umbrella Trial for First-line Precision Therapy With TROP2 in Patients With Locally Advanced or Metastatic TNBC (Future-Trop2 Study)

Last checked: Nov 19, 2026Latest source record: Jul 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 125 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

125

Planned (sponsor's estimate)

Start

Jul 1, 2023

Primary completion

Mar 1, 2024

Study completion Sep 1, 2025

Sponsor

Lead sponsor
Fudan UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 3, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To explore the efficacy and safety of TROP2 in the treatment of ABC

Conditions

  • TNBC - Triple-Negative Breast Cancer

Interventions

  • A1:SG with SHR3680Drug

    SG 10mg/kg d1, 8;SHR3680 240mg qd,3 weeks is a cycle

  • A2:SGDrug

    SG 10mg/kg d1, 8

  • B1:SG with SHR1210Drug

    SG 10mg/kg, d1, 8;SHR1210 200mg,d1,q3w;

  • B2:SGDrug

    SG 10mg/kg, d1, 8

  • C1:SG with SHR3162Drug

    SG 10mg/kg d1, 8;SHR3162,150mg,QD ,3 weeks is a cycle

  • C2:SGDrug

    SG 10mg/kg d1, 8

  • D1:SG with VEGFRIDrug

    SG 10mg/kg,d1, 8;BP102 15mg/kg,d1,3 weeks is a cycle

  • D2:SGDrug

    SG 10mg/kg d1, 8

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. PFSTime frame: max 6 months

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.